[1] [1] LIN X T, ZHUANG S W, CHEN X,et al. lncRNA ITGB8-AS1 functions as a ceRNA to promote colorectal cancer growth and migration through integrin-mediated focal adhesion signaling[J]. Mol Ther, 2022, 30(2): 688-702. DOI:10.1016/j.ymthe.2021.08.011.

[2] [2] ZHAO W H, DAI S P, YUE L,et al. Emerging mechanisms progress of colorectal cancer liver metastasis[J/OL]. Front Endocrinol, 2022, 13:1081585[2024-08-28]. https://pubmed.ncbi.nlm.nih.gov/36568117/. DOI:10.3389/fendo.2022.1081585.

[3] [3] MAO Y N, WANG W, YANG J W,et al. Drug repurposing screening and mechanism analysis based on human colorectal cancer organoids[J]. Protein Cell, 2024, 15(4): 285-304. DOI:10.1093/procel/pwad038.

[4] [4] DODANGEH F, SADEGHI Z, MALEKI P,et al. Long non-coding RNA SOX2-OT enhances cancer biological traitsviasponging to tumor suppressor miR-122-3p and miR-194-5p in non-small cell lung carcinoma[J/OL]. Sci Rep, 2023, 13(1): 12371[2024-08-28]. https://pubmed.ncbi.nlm.nih.gov/37524903/. DOI:10.1038/s41598-023-39000-0.

[5] [5] WANG H C, HU Q L, TONG Y L,et al. lncRNA SOX2-OT regulates miR-192-5p/RAB2A axis and ERK pathway to promote glioblastoma cell growth[J]. Cell Cycle, 2021, 20(19): 2010-2020. DOI:10.1080/15384101.2021.1965722.

[6] [6] CHENG Y, HAN X J, MO F,et al. Apigenin inhibits the growth of colorectal cancer through down-regulation of E2F1/3 by miRNA-215-5p[J]. Phytomedicine, 2021, 89: 153603[2024-08-28]. https://pubmed.ncbi.nlm.nih.gov/34175590/. DOI:10.1016/j.phymed.2021.153603.

[7] [7] GAO J B, ZHU M N, ZHU X L. miRNA-215-5p suppresses the aggressiveness of breast cancer cells by targeting Sox9[J]. FEBS Open Bio, 2019, 9(11): 1957-1967. DOI:10.1002/2211-5463.12733.

[8] [8] REN Z, YAO L Q, LIU J Z,et al. Silencing NOB1 can affect cell proliferation and apoptosisviathe C-Jun N-terminal kinase pathway in colorectal cancer[J]. J Invest Surg, 2021, 34(8): 819-825. DOI:10.1080/08941939.2019.1697401.

[10] [10] YANG X, ZHANG S, HE C Y,et al. METTL14 suppresses proliferation and metastasis of colorectal cancer by down-regulating oncogenic long non-coding RNA XIST[J/OL]. Mol Cancer, 2020, 19(1): 46[2024-08-28]. https://pubmed.ncbi.nlm.nih.gov/32111213/. DOI:10.1186/s12943-020-1146-4.

[12] [12] MURPHY C C, ZAKI T A. Changing epidemiology of colorectal cancer-birth cohort effects and emerging risk factors[J]. Nat Rev Gastroenterol Hepatol, 2024, 21: 25-34. DOI:10.1038/s41575-023-00841-9.

[13] [13] SONG X F, WANG H, WU J W,et al. Long noncoding RNA SOX2-OT knockdown inhibits proliferation and metastasis of prostate cancer cells through modulating the miR-452-5p/HMGB3 axis and inactivating Wnt/-catenin pathway[J]. Cancer Biother Radiopharm, 2020, 35(9):682-695. DOI:10.1089/cbr.2019.3479.

[14] [14] LI G, PAN C C, SUN J Q,et al. lncRNA SOX2-OT regulates laryngeal cancer cell proliferation, migration and invasion and induces apoptosis by suppressing miR-654[J]. Exp Ther Med, 2020,19(5): 3316-3324. DOI:10.3892/etm.2020.8577.

[15] [15] YANG S, ZHANG D S, SUN Q Y,et al. Single-cell and spatial transcriptome profiling identifies the transcription factor BHLHE40 as a driver of EMT in metastatic colorectal cancer[J]. Cancer Res,2024, 84(13): 2202-2217. DOI:10.1158/0008-5472.CAN-23-3264.

[16] [16] CHEN G, TIAN T T, WANG F Q,et al. Chanling Gao suppresses colorectal cancerviaPI3K/Akt/mTOR pathway modulation and enhances quality of survival[J]. Environ Toxicol, 2024, 39(3): 1107-1118. DOI:10.1002/tox.23994.

[17] [17] KANDHAVELU J, SUBRAMANIAN K, NAIDOO V,et al. A novel EGFR inhibitor, HNPMI, regulates apoptosis and oncogenesis by modulating BCL-2/BAX and p53 in colon cancer[J]. Br J Pharmacol,2024, 181(1): 107-124. DOI:10.1111/bph.16141.

[18] [18] WU C L, XU L L, PENG J,et al. Al-MPS obstructs EMT in breast cancer by inhibiting lipid metabolismviamiR-215-5p/SREBP1[J/OL]. Endocrinology, 2022, 163(5): bqac040[2024-08-28]. https://pubmed.ncbi.nlm.nih.gov/35366327/. DOI:10.1210/endocr/bqac040.

[19] [19] MACHACKOVA T, VYCHYTILOVA-FALTEJSKOVA P, SOUCKOVA K,et al. miR-215-5p reduces liver metastasis in an experimental model of colorectal cancer through regulation of ECM-receptor interactions and focal adhesion[J/OL]. Cancers, 2020, 12(12): 3518[2024-08-28]. https://pubmed.ncbi.nlm.nih.gov/33255928/. DOI:10.3390/cancers12123518.

[21] [21] SHI Z K, ZHOU X, BAO M J,et al. miRNA-612 suppresses ovarian cancer cell tumorigenicity by downregulating NOB1[J/OL]. Am J Transl Res, 2022, 14(6): 3904-3914[2024-08-28]. https://pmc.ncbi.nlm.nih.gov/articles/PMC9274555/.

[22] [22] DONG S, XUE S, SUN Y,et al. MicroRNA-363-3p downregulation in papillary thyroid cancer inhibits tumor progression by targeting NOB1[J]. J Investig Med, 2021, 69(1): 66-74. DOI:10.1136/jim-2020-001562.